A new HIV vaccine has shown promise in Phase I trials. "The vaccine successfully stimulated the production of the rare immune cells needed to generate antibodies against HIV in 97 percent of participants." [europeanpharmaceuticalreview.com]
---
Note: Quick Links are pushed to this RSS feed twice a day. For more immediate service, check out the front page of kottke.org, the Quick Links archive, or the @kottke Twitter feed.
from kottke.org https://ift.tt/3ac8g8Y
via IFTTT
EmoticonEmoticon